Aslaksen Per Matti, Zwarg Maria Lorentze, Eilertsen Hans-Ingvald Hage, Gorecka Marta Maria, Bjørkedal Espen
Department of Psychology, Faculty of Health Sciences, University of Tromsø-The Arctic University of Norway, 9037 Tromsø, Norway.
Pain. 2015 Jan;156(1):39-46. doi: 10.1016/j.pain.0000000000000004.
Several studies have shown that psychological factors such as learning, expectation, and emotions can affect pharmacological treatment and shape both favorable and adverse effects of drugs. This study investigated whether nocebo information provided during administration of an analgesic cream could reverse topical analgesia to hyperalgesia. Furthermore, we tested whether nocebo effects were mediated by negative emotional activation. A total of 142 healthy volunteers (73 women) were randomized into 6 groups. A topical analgesic cream (Emla) was administered together with suggestions of analgesia in 1 group, whereas another group received Emla with suggestions of hyperalgesia. Two other groups received a placebo cream together with the same information as the groups receiving Emla. A fifth group received Emla with no specific information about the effect, and the sixth group received no treatment but the same pain induction as the other groups. Heat pain stimulation (48°C) was administered during a pretest and 2 posttests. Pain was continuously recorded during stimulation, and measures of subjective stress and blood pressure were obtained before the pretest, after the application of cream, and after the posttests. The results revealed that pain was significantly lower in the group receiving Emla with positive information and highest in the groups receiving suggestions of hyperalgesia, regardless of whether Emla or the placebo was administered. Mediation analyses showed that stress and blood pressure mediated hyperalgesia after nocebo suggestions. These results suggest that nocebo information can reverse topical analgesia and that emotional factors can explain a significant proportion of variance in nocebo hyperalgesia.
多项研究表明,学习、期望和情绪等心理因素会影响药物治疗,并塑造药物的有利和不利影响。本研究调查了在使用镇痛乳膏过程中提供的反安慰剂信息是否会将局部镇痛转变为痛觉过敏。此外,我们还测试了反安慰剂效应是否由负面情绪激活介导。共有142名健康志愿者(73名女性)被随机分为6组。一组在使用局部镇痛乳膏(复方利多卡因乳膏)时给予镇痛提示,而另一组在使用复方利多卡因乳膏时给予痛觉过敏提示。另外两组接受安慰剂乳膏,并给予与接受复方利多卡因乳膏的组相同的信息。第五组使用复方利多卡因乳膏,但未提供关于其效果的具体信息,第六组未接受治疗,但接受与其他组相同的疼痛诱导。在一次预测试和两次后测试期间进行热痛刺激(48°C)。在刺激过程中持续记录疼痛情况,并在预测试前、涂抹乳膏后和后测试后获取主观应激和血压测量值。结果显示,无论使用的是复方利多卡因乳膏还是安慰剂,接受积极信息的复方利多卡因乳膏组的疼痛明显更低,而接受痛觉过敏提示的组疼痛最高。中介分析表明,反安慰剂提示后,应激和血压介导了痛觉过敏。这些结果表明,反安慰剂信息可以逆转局部镇痛,并且情绪因素可以解释反安慰剂痛觉过敏中很大一部分的变异。